BLUE BIOFUELS, INC.
Datakwaliteit: 83%
BIOF
OTC
Manufacturing
Chemicals
€ 0,16
€ 0,00
(0,00%)
Marktkapitalisatie: 48,37 M
Prijs
€ 0,15
Marktkapitalisatie
48,37 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -913.900,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,04
Interest CoverageN/A
Waardering
PE (TTM)
-16,83
Onder sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -16,8 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,9 |
| D/E | — | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -2,87 M |
| ROE | N/A | ROA | -195,92% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -913.900,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,04 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -2,29 M | Tangible Book Value | -3,06 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -16,83 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -1,89% | ||
| Market Cap | 48,37 M | Enterprise Value | 48,27 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,01 | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 31,79% |
| SBC-Adj. FCF | -1,75 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -2,87 M | -1,42 M | -3,06 M | -3,96 M | -2,14 M |
| EPS (Diluted) | -0,01 | -0,01 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -3,72 M | -4,06 M | -3,19 M | -3,93 M | -2,17 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 2,31 M | 2,33 M | 1,85 M | 2,35 M | 1,10 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 145.852,0 | 118.798,0 | 216.785,0 | 138.464,0 | 131.715,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,41 M | 1,39 M | 1,03 M | 1,11 M | 1,84 M |
| Total Liabilities | 5,11 M | 4,24 M | 4,59 M | 3,46 M | 3,23 M |
| Shareholders' Equity | -3,71 M | -2,85 M | -3,56 M | -2,36 M | -1,40 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 65.200,0 | 48.797,0 | 41.008,0 | 211.901,0 | 1,16 M |
| Current Assets | 76.751,0 | 81.286,0 | 76.758,0 | 255.020,0 | 1,21 M |
| Current Liabilities | 2,98 M | 2,21 M | 1,50 M | 638.721,0 | 496.161,0 |
{"event":"ticker_viewed","properties":{"ticker":"BIOF","listing_kind":"stock","pathname":"/stocks/biof","exchange":"OTC","country":"US"}}